ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.74146
-0.32%
Brent Oil
84.255
0.36%
Bitcoin
63,004.91
-0.07%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Brooklyn ImmunoTherapeutics Inc (BTX)

  7. Brooklyn ImmunoTherapeutics Inc (BTX) Noticias

BTX

Brooklyn ImmunoTherapeut... (BTX)

Brooklyn ImmunoTherapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:BTX
FechaHoraFuenteTítuloSímboloCompañía
11/05/202315:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
10/05/202305:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202306:02Edgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202306:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202305:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
25/04/202308:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/04/202315:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202316:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202316:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/12/202215:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
16/12/202216:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/12/202215:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
06/12/202217:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
02/12/202216:01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/04/202215:35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
15/04/202216:10Edgar (US Regulatory)Annual Report (10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/04/202205:31Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/11/202105:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202116:12Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202116:00Edgar (US Regulatory)Withdrawal of Registration Statement (rw)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202115:52Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
09/11/202115:35GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial ResultsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202115:22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202115:13Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202115:06Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/10/202115:15GlobeNewswire Inc.Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to NasdaqAMEX:BTXBrooklyn ImmunoTherapeutics Inc
12/10/202116:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/10/202115:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
23/09/202115:30GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Reports Inducement GrantsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/09/202109:07GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical OfficerAMEX:BTXBrooklyn ImmunoTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:BTX

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
CCOM
OILBRENT
Brent Oil
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
CCOM
US30
US 30
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLF
Financial Select Sector
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados